
|Articles|June 14, 2012
Great Strides Made In Developing New Medicines For Cancer
Advertisement
While there has been a great deal of discussion around Obamacare and the Supreme Court ruling that is expected to be announced in the near future, much progress has been made in other areas of public health that has gone largely unnoticed.
A report released earlier this month found that there are 981 medicines and vaccines currently being tested by America’s biopharmaceutical research companies to fight the various types of cancer affecting millions of patients around the world. The potential medicines, which are either in clinical trials or under review by the FDA, include 121 for lung cancer, 117 for lymphoma and 111 for breast cancer.
Read the full story:
Source: Forbes
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
3
Beyond GLP-1: The Biological Case for Dual Incretin Therapy in MASH
4
Stem Cell Transplant Outperforms DMTs in Drug-Resistant Relapsing MS
5




